Literature DB >> 32658314

A survey of herbal medicines as tumor microenvironment-modulating agents.

Chan-Ran Park1,2,3, Jin-Seok Lee2,3, Chang-Gue Son2,3, Nam-Hun Lee1,2,3.   

Abstract

The tumor microenvironment (TME) is extremely complex, involving extensive interactions among stromal cells, immune cells, and signaling molecules. Therefore, an approach targeting the TME has emerged as a promising therapeutic strategy. Herbal medicines consist of multiple active compounds, which have multi-target effects. Therefore, they have been regarded as potential anticancer agents; multiple studies have explored their effects on the TME. In this review, we report the effects of 29 single herb medicines or herbal formulas on the TME, based on the findings of 64 published studies. Specifically, we describe the effects of these herbal medicines on cancer-associated fibroblasts/tumor-associated fibroblasts, tumor-associated endothelial cells, myeloid-derived suppressor cells, and tumor-associated macrophages. Among the reviewed herbal medicines, the most promising TME-modulating effects were exhibited by curcumin, DHA, EGCG, resveratrol, and silibinin; these medicines showed the ability to regulate two or more components of the TME. The findings of this review support the notion that the combination of herbal medicines with conventional anticancer therapies are likely to exhibit a clinical benefit, which should be further explored in clinical trials.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer-associated fibroblasts; herbal medicine; myeloid-derived suppressor cells; tumor microenvironment; tumor-associated endothelial cells; tumor-associated macrophages

Year:  2020        PMID: 32658314     DOI: 10.1002/ptr.6784

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach.

Authors:  Wanying Lang; Feng Yang; Fanfan Cai; Wengui Shi; Min Dong; Qi An; Yanping Li
Journal:  Comput Intell Neurosci       Date:  2022-07-16

2.  The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.

Authors:  Yin Duan; Hui-Ling Chen; Min Ling; Shuo Zhang; Fei-Xia Ma; Hong-Chen Zhang; Xiao-Ai Lv
Journal:  Mol Cell Biol       Date:  2021-11-15       Impact factor: 5.069

Review 3.  Targeting of the tumor immune microenvironment by metformin.

Authors:  Zihong Wu; Caidie Zhang; Masoud Najafi
Journal:  J Cell Commun Signal       Date:  2021-10-05       Impact factor: 5.908

4.  Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts.

Authors:  Shuhai Chen; Masaaki Nishi; Yuji Morine; Mitsuo Shimada; Takuya Tokunaga; Hideya Kashihara; Chie Takasu; Shinichiro Yamada; Yuma Wada
Journal:  Int J Oncol       Date:  2022-01-14       Impact factor: 5.650

5.  Synergistic effects of herbal medicines and anticancer drugs: A protocol for systematic review and meta-analysis.

Authors:  Chunhoo Cheon
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

6.  Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol.

Authors:  Chunhoo Cheon; Seong-Gyu Ko
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.